biotech
Optimizer III Implantable Pulse Generator Against Heart Failure
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics , Other Biotechnology News by ruth on October 19, 2006
Optimizer III Implantable Pulse Generator Against Heart Failure
Impulse Dynamics is conducting a Phase II clinical trial to evaluate an implantable device designed to treat heart failure, called Optimizer.
Optimizer™ technology is based on a new method known as Cardiac Contractility Modulation (CCM). CCM is a method for treating failing hearts in which non-excitatory impulses are delivered to the heart during a period of time called the absolute refractory period (ARP). Therefore, these signals do not initiate the heart to beat (like a pacemaker would). Rather, these signals are intended to modify heart cell function for the treatment of heart failure.

Approximately 420 patients in about 50 sites nationwide will be enrolled in this trial. Patients who qualify will undergo surgery similar to putting in a pacemaker.

Recruitment are currenlty being done on major university hospitals across the country. If you would like to participate, or would like more information, check if you meet the eligibility criteria, or email info@impulse-dynamics.com.


Permalink: Optimizer III Implantable Pulse Generator Against Heart Failure
Tags: clinical+trial  heart+failure  pacemaker 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/39672
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Optimizer III Implantable Pulse Generator Against Heart Failure:

  • Currently 8.33/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.33 out of 3 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!